<DOC>
	<DOCNO>NCT02031432</DOCNO>
	<brief_summary>The purpose trial find well cebranopadol tolerate often , , adverse reaction occur take every day long period time . In addition information collect cebranopadol affect pain well-being patient suffer cancer-related pain .</brief_summary>
	<brief_title>CORAL XT - Open-label Extension Trial CORAL Trial</brief_title>
	<detailed_description>The trial consist 3 phase : Titration Phase , Maintenance Phase , Follow-Up . The total duration trial approximately 28 week individual participant , include Follow-up . The participant receive cebranopadol maximum approximately 26 week .</detailed_description>
	<mesh_term>Chronic Pain</mesh_term>
	<criteria>Informed consent sign indicate participant understands purpose procedure require trial willing participate trial . Participants must least 18 year age Enrollment Visit . Women childbearing potential must negative pregnancy test enrollment must lactate Enrollment Visit . Participants must willing use medically acceptable highly effective method birth control . Participants complete treatment KF6005/07 still need aroundtheclock pain analgesia strong opioids . The participant clinically significant disease condition cancer investigator 's opinion may affect efficacy safety assessment . Known suspect able comply protocol use cebranopadol . Participants take forbidden concomitant medication able follow rule use concomitant treatment . History torsade de pointes and/or presence risk factor torsade de pointes ( e.g. , heart failure , hypokalemia , bradycardia ) . Concurrent participation another trial ( except participation KF6005/07 ) planning enrol another clinical trial ( i.e. , administration experimental treatment another clinical trial ) course trial , previous participation trial . Employees sponsor , investigator , trial site family member employee , sponsor , investigator .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>cancer-related pain</keyword>
	<keyword>cebranopadol</keyword>
</DOC>